Latest Regulatory Approvals News

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.

Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.

Nickel Industries has secured a significant increase in its 2026 ore sales license and finalized a long-term supply agreement for its Excelsior Nickel Cobalt project, enhancing production certainty and sustainability.

Challenger Limited’s attempt to acquire Pepper Money has been declined by Pepper’s board, while Challenger moves forward with a $150 million share buy-back program.

Forrestania Resources has announced a JORC-compliant Mineral Resource Estimate of 103,500 ounces of gold at its Johnson Range Project, fulfilling a key condition for acquiring Aurumin Johnson Range Pty Ltd and Aurumin Mt Dimer Pty Ltd from Newcam Minerals.

Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.

Native Mineral Resources (ASX: NMR) has updated its drilling results at the Podosky deposit in Queensland, confirming shallow, high-grade gold mineralisation that supports near-term open-pit mining plans. Mining activities are targeted to commence in April 2026.

Avira Resources has validated significant high-grade gold intersections at its Mt Cattlin Gold Project, underpinning plans for a maiden Mineral Resource Estimate by the end of 2026. The company is poised to commence drilling in Q2 to test extensions across multiple prospects.

Echo IQ has strengthened its partnership with Mayo Clinic to distribute its AI-driven heart failure diagnostic tool, EchoSolv HF, pending FDA clearance. The expanded agreement offers a scalable commercial pathway across a vast US hospital network.

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

Sentinel Metals has reached a pivotal regulatory milestone as its Columbia Gold-Silver Project’s exploration amendment enters the public comment phase, paving the way for maiden drilling expected in April 2026.